Oricula Therapeutics LlcCompany Details

Get alertedif Oricula Therapeutics Llc gets funded!
Oricula Therapeutics LlcFunding history
Key people
Country:
State:
City:
United States
Washington
Seattle
Industry:Biotechnology
Detailed industries:biotechnology
Company description

Oricula Therapeutics, LLC, is working to develop the first medication approved to prevent hearing loss. Our first product will prevent hearing loss as a frequent side effect of an important class of antibiotic, aminoglycosides. Oricula research is progressing towards a FDA Investigational New Drug filing for this product. Reducing or eliminating hearing loss as a side effect of aminoglycoside therapy would allow broader worldwide use of these important antibiotics for the treatment of life-threatening bacterial infections, such as endocarditis, neonatal ...septicemia and multi-drug resistant tuberculosis. MoreLess

 

Funding history

DateDeal sizeInvestors 
April 30th, 2014$169,398National Institutes Of HealthView Deal
November 4th, 2013$75,000-View Deal
Create alert
Want to know when Oricula Therapeutics Llc gets funded?
Key people
Malcolm A. GleserCEO
Malcolm GleserDirector, Executive Officer, Promoter
Vince GroppiDirector, Promoter
Ed RubelDirector, Promoter
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!